ERTUMAXOMAB

Investigational

Approval Year

Substance Class	Protein
Protein Type	BISPECIFIC ANTIBODY
Protein Sub Type	IGG2A
Sequence Origin	RAT-MURINE HYBRID
Sequence Type	INCOMPLETE
Record UNII	L5L45YGP1O
Record Status	`Validated (UNII)`
Record Version

Show entries

Name

Type

Language

ERTUMAXOMAB

Official Name

English

ertumaxomab [INN]

Common Name

English

ANTI-CD3 X ANTI-HER-2-NEU BISPECIFIC MONOCLONAL ANTIBODY

Common Name

English

Ertumaxomab [WHO-DD]

Common Name

English

Showing 1 to 4 of 4 entries

Previous1Next

Show entries

Classification Tree

Code System

Code

Antineoplastic Biological Agent

NCI_THESAURUS

C129822

Biological Agent

NCI_THESAURUS

C1454

Showing 1 to 2 of 2 entries

Previous1Next

Show entries

Code System

Code

Type

Description

CAS

509077-99-0

PRIMARY

INN

8407

PRIMARY

NCI_THESAURUS

C2658

PRIMARY

ChEMBL

CHEMBL2108029

PRIMARY

FDA UNII

L5L45YGP1O

PRIMARY

Showing 1 to 5 of 7 entries

Previous1 2Next

Subunit 0

Subunit 1

Subunit 2

Subunit 3

Show entries

Related Record

Type

Details


					ZLW14X2D30

CD3

TARGET -> ACTIVATOR

Amount:

Showing 1 to 1 of 1 entries

Previous1Next

Show entries

Related Record

Type

Details


					L5L45YGP1O

ERTUMAXOMAB

ACTIVE MOIETY

Amount:

Showing 1 to 1 of 1 entries

Previous1Next

Show entries

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL	ESTIMATED
Molecular Formula	CHEMICAL	ESTIMATED C281H468N78O101S

Showing 1 to 2 of 2 entries

Previous1Next